Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
2.460
-0.360 (-12.77%)
At close: Jan 28, 2026, 4:00 PM EST
2.490
+0.030 (1.22%)
After-hours: Jan 28, 2026, 4:53 PM EST
Traws Pharma Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Traws Pharma stock has a target of 8.00, which predicts a 225.20% increase from the current stock price of 2.46.
Price Target: $8.00 (+225.20%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 3, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Traws Pharma is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 |
|---|---|---|
| Strong Buy | 1 | 1 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +225.20% | Dec 3, 2025 |
Financial Forecast
Revenue This Year
2.86M
from 226.00K
Increased by 1,163.72%
Revenue Next Year
n/a
from 2.86M
EPS This Year
-0.04
from -35.21
EPS Next Year
-2.35
from -0.04
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.9M | n/a | |
| Avg | 2.9M | n/a | |
| Low | 2.7M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1,200.9% | - | |
| Avg | 1,163.7% | - | |
| Low | 1,114.2% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.04 | -2.42 | |
| Avg | -0.04 | -2.35 | |
| Low | -0.04 | -2.25 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.